NEA Management Company, LLC
CIK 1512848 · View on SEC EDGAR ↗
- Portfolio value
- $1.6B
- Positions
- 26
- As of
- June 30, 2026
#1,786 of 9,443 by 13F value · top 18.9%
Portfolio value QoQ: -9.7% 13F does not disclose cash
- Top 10 holdings weight
- 89.82%
- Top 25 holdings weight
- 99.99%
- Positions above 1%
- 13
- Effective number of positions
- 10.3
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 0.34% Est. buys $5,635,141 · sells $410,181,728
Median holding: 5.5 quarters Tracked Q4 2024–Q2 2026 · 56.5% still held
- New positions
- 1
- Increased
- 0
- Decreased
- 2
- Closed
- 1
On this page
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
Sector breakdown
Healthcare
83.8%
Diversified Consumer Services
4.6%
Other/Unmapped
11.6%
Full portfolio 26 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| TRVI Trevi Therapeutics, Inc. - Common Stock | $246,594,552 | 15.53% | 13,222,228 | $88,853,372 | |||
| MBX MBX Biosciences, Inc. - Common Stock | $199,519,627 | 12.56% | 3,614,486 | $91,627,220 | |||
| GLUE Monte Rosa Therapeutics, Inc. - Common Stock | $186,153,612 | 11.72% | 7,692,298 | $59,615,310 | |||
| CELC Celcuity Inc. - Common Stock | $178,958,892 | 11.27% | 1,710,561 | $-81,915,041 | Down ×2 | ||
| SGP SpyGlass Pharma, Inc. - Common Stock | $164,552,620 | 10.36% | 7,392,301 | $-26,981,899 | |||
| SVRA Savara, Inc. - Common Stock | $150,742,986 | 9.49% | 24,471,264 | $17,129,885 | |||
| ZBIO Zenas BioPharma, Inc. - Common Stock | $102,109,298 | 6.43% | 4,023,219 | $23,455,367 | |||
| COUR Coursera, Inc. Common Stock | $72,574,217 | 4.57% | 12,867,769 | $-2,316,199 | |||
| AUPH Aurinia Pharmaceuticals Inc - Common Shares | $67,368,083 | 4.24% | 3,969,834 | $8,535,143 | |||
| CRSP CRISPR Therapeutics AG - Common Shares | $57,734,408 | 3.64% | 1,058,570 | $7,378,233 | |||
| ORIC Oric Pharmaceuticals, Inc. - Common Stock | $44,604,665 | 2.81% | 4,118,621 | $-7,578,263 | |||
| PHAT Phathom Pharmaceuticals, Inc. - Common Stock | $21,267,834 | 1.34% | 1,960,169 | $-509,644 | |||
| KRRO Korro Bio, Inc. - Common Stock | $17,106,230 | 1.08% | 1,297,893 | $2,414,081 | |||
| XFORXXXX | $15,101,580 | 0.95% | 3,233,743 | $1,746,221 | |||
| CSBR Champions Oncology, Inc. - Common Stock | $10,556,515 | 0.66% | 1,713,720 | $702,625 | |||
| NKTX Nkarta, Inc. - Common Stock | $10,099,650 | 0.64% | 3,568,781 | $2,569,522 | |||
| CVRX CVRx, Inc. - Common Stock | $10,045,822 | 0.63% | 1,954,440 | $-9,120,923 | Down ×1 | ||
| BDTX Black Diamond Therapeutics, Inc. - Common Stock | $8,230,200 | 0.52% | 4,448,757 | $-1,245,652 | |||
| KPTI Karyopharm Therapeutics Inc. - Common Stock | $5,635,141 | 0.35% | 576,780 | Up ×1 | |||
| IVA Inventiva S.A. - American Depository Shares | $5,528,575 | 0.35% | 1,462,586 | $-2,501,022 | |||
| LONA LeonaBio, Inc. - Common Stock | $4,267,818 | 0.27% | 464,398 | $-506,193 | |||
| SNTI Senti Biosciences, Inc. - Common Stock | $4,153,177 | 0.26% | 3,775,615 | $1,087,378 | |||
| MRKR Marker Therapeutics, Inc. - Common Stock | $2,389,747 | 0.15% | 1,625,678 | $276,366 | |||
| OKUR OnKure Therapeutics, Inc. - Class A Common Stock | $2,182,179 | 0.14% | 478,548 | $200,990 | |||
| IMA ImageneBio, Inc. - Common Stock | $295,030 | 0.02% | 50,005 | $45,005 | |||
| GOSS Gossamer Bio, Inc. - Common Stock | $164,600 | 0.01% | 1,000,000 | $-163,900 | |||
| No matches | |||||||
Biggest new bets
New positions opened this quarter, largest first.
| Security | Value | Shares | % of portfolio |
|---|---|---|---|
| KPTI | $5,635,141 | 576,780 | 0.35% |
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| MBX | Price move only | +0 | +$91.6M |
| TRVI | Price move only | +0 | +$88.9M |
| CELC | Trimmed | -575K | -$81.9M |
| GLUE | Price move only | +0 | +$59.6M |
| SGP | Price move only | +0 | -$27.0M |
| ZBIO | Price move only | +0 | +$23.5M |
| SVRA | Price move only | +0 | +$17.1M |
| CVRX | Trimmed | -72K | -$9.1M |
| AUPH | Price move only | +0 | +$8.5M |
| ORIC | Price move only | +0 | -$7.6M |
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| ACLX | June 30, 2026 | 3,045,262 | $349,656,983 | No longer tracked |
| RYTM | March 31, 2026 | 2,909,956 | $311,481,690 | 26.2% |
| VRNA | Dec. 31, 2025 | 2,252,994 | $240,416,990 | No longer tracked |
| NN | March 31, 2025 | 8,189,156 | $127,423,267 | 50.7% |
| TEM | June 30, 2025 | 2,615,979 | $126,194,827 | 4.5% |
| NEUE | Dec. 31, 2025 | 2,726,917 | $18,188,536 | No longer tracked |
| RGLS | June 30, 2025 | 6,467,802 | $11,318,654 | No longer tracked |
| GERN | March 31, 2025 | 2,776,409 | $9,828,488 | -2.2% |
| INZY | Sept. 30, 2025 | 2,437,689 | $9,750,756 | No longer tracked |
| SGMT | March 31, 2025 | 2,000,275 | $9,001,238 | 213.8% |
| OMDA | Dec. 31, 2025 | 364,115 | $8,050,583 | 49.8% |
| DM | June 30, 2025 | 1,439,892 | $7,069,869 | No longer tracked |
| BZFD | June 30, 2025 | 2,512,103 | $5,350,779 | -44.7% |
| ADAPY | Sept. 30, 2025 | 17,079,778 | $4,094,023 | No longer tracked |
| SYBX | March 31, 2026 | 2,922,772 | $3,273,505 | No longer tracked |
| LXRX | March 31, 2025 | 2,382,286 | $1,759,318 | 394.6% |
| ALLK | June 30, 2025 | 6,147,260 | $1,399,116 | No longer tracked |
| IKNA | Sept. 30, 2025 | 600,063 | $804,084 | No longer tracked |
| AFMDQ | June 30, 2025 | 442,648 | $320,123 | No longer tracked |
| UP | Sept. 30, 2025 | 106,125 | $113,554 | 166.8% |